Skip to main navigation Skip to search Skip to main content

Synthesis, Characterization, and Function of an RNA-Based Transfection Reagent

  • United States Food and Drug Administration
  • Children's National Medical Center
  • George Washington University

Research output: Contribution to journalArticlepeer-review

Abstract

A synthetic 8-mer, amphipathic, trans-acting poly-2′-O-methyluridylic thiophosphate triester RNA element (2′-OMeUtaPS) can be prepared using solid-phase synthesis protocols. 2′-OMeUtaPS efficiently mediates the delivery of uncharged polyA-tailed phosphorodiamidate morpholino (PMO) sequences in HeLa pLuc 705 cells, as evidenced by flow cytometry measurements. In this cell line, 2′-OMeUtaPS-mediated transfection of an antisense polyA-tailed PMO sequence induces alternative splicing of an aberrant luciferase pre-mRNA splice site, leading to restoration of functional luciferase, as quantitatively measured using a typical luciferase assay. 2′-OMeUtaPS is also potent at delivering an uncharged antisense polyA-tailed PMO sequence in muscle cells of the mdx mouse model of muscular dystrophy; targeting the polyA-tailed PMO sequence against a splice site of the pre-mRNA encoding mutated dystrophin triggers an alternate splicing event that results in excision of the mutated exon (exon 23) from the pre-mRNA and production of functional dystrophin, as demonstrated by agarose gel electrophoresis.

Original languageEnglish
Pages (from-to)4.81.1-4.81.29
JournalCurrent Protocols in Nucleic Acid Chemistry
Volume72
Issue number1
DOIs
StatePublished - Mar 2018

Keywords

  • cellular PMO uptake
  • dystrophin pre-mRNA
  • exon 23 excision
  • luciferase pre-mRNA
  • pre-mRNA splicing

Fingerprint

Dive into the research topics of 'Synthesis, Characterization, and Function of an RNA-Based Transfection Reagent'. Together they form a unique fingerprint.

Cite this